Atlas Trials

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

Clinical trial NCT04784442 · COMPLETED

Trial details

NCT number
NCT04784442
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2021-03-24
Primary completion
2022-04-18
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.